1. Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing. (24th March 2018) Authors: Aqrawi, L. A.; Ivanchenko, M.; Björk, A.; Ramírez Sepúlveda, J. I.; Imgenberg‐Kreuz, J.; Kvarnström, M.; Haselmayer, P.; Jensen, J. L.; Nordmark, G.; Chemin, K.; Skarstein, K.; Wahren‐Herlenius, M. Journal: Clinical and experimental immunology Issue: Volume 192:Number 3(2018:Jun.) Page Start: 259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0272 Pharmacodynamic effects of atacicept treatment in a cynomolgus monkey klh antigen challenge model. (12th June 2018) Authors: Samy, E.; Bender, A.; Wu, Y.; Castagna, V.; Bertotti, E.; Boggio, R.; Paoletti, A.; Riva, S.; Schneider, P.; Haselmayer, P.; DeMartino, J. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 674 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0322 Rationale for the atacicept dose for a phase iii study in patients with highly active and auto-antibody positive sle. (12th June 2018) Authors: Shen, J.; Papasouliotis, O.; Samy, E.; Haselmayer, P.; Chang, P.; Ona, V.; Kao, A. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 697 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0245 Individual versus Combined BLYs Or/and april Neutralization Reveals Developmental Plasticity for Plasma Cell Survival Factor Requirements. (15th July 2016) Authors: Haselmayer, P.; Vigolo, M.; Nys, J.; Schneider, P.; Hess, H. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0275 Pharmacodynamic Modeling of BTK Occupancy versus Efficacy in RA and SLE Models Using The Novel Specific BTK Inhibitor M2951. (15th July 2016) Authors: Haselmayer, P.; Camps, M.; Liu-Bujalski, L.; Morandi, F.; Head, J.; Zimmerli, S.; Bruns, L.; Bender, A.; Schroeder, P.; Grenningloh, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗